The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Broudy, V. C.
Right arrow Articles by Adamson, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Broudy, V. C.
Right arrow Articles by Adamson, J. W.

The Journal of Immunology, Vol 138, Issue 12 4298-4302, Copyright © 1987 by American Association of Immunologists


ARTICLES

Disparate effects of tumor necrosis factor-alpha/cachectin and tumor necrosis factor-beta/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion molecule expression by cultured human endothelial cells

VC Broudy, JM Harlan and JW Adamson

Tumor necrosis factor-alpha/cachectin (TNF-alpha) and tumor necrosis factor-beta/lymphotoxin (TNF-beta) are inflammatory mediators with similar spectrums of cytotoxic activity against tumors in vitro and in vivo. We compared the effect of purified recombinant human TNF-alpha and TNF-beta on neutrophil adhesion molecule expression and hematopoietic growth factor production by cultured human umbilical vein endothelial cells. Endothelial cells acquired adhesive properties for neutrophils after a 4-hr incubation with as little as 5 U/ml TNF-alpha. TNF-alpha stimulated a dose-dependent increase in endothelial cell adhesiveness for neutrophils, with a maximal effect at 250 U/ml. In contrast, TNF-beta did not enhance endothelial-dependent neutrophil adherence until a concentration of 600 to 1200 U/ml was reached. Endothelial cells cultured for 24 hr with TNF-alpha, 10 to 1,000 U/ml, released hematopoietic colony-stimulating activity. TNF-beta failed to augment growth factor production by endothelial cells at any concentration tested. Inhibitor assays showed that the absence of detectable colony-stimulating activity was not due to direct inhibition of colony growth by TNF-beta or to release of hematopoietic inhibitors by the TNF-beta-stimulated endothelial cells. Purified natural TNF-beta was similar to recombinant TNF-beta in its effect on neutrophil adhesion molecule expression and growth factor production by endothelial cells. These results indicate that the two immunomodulatory proteins TNF-alpha and TNF-beta differ in their effects on a common target tissue. TNF-beta, which retains tumoricidal properties, shows fewer proinflammatory activities on cultured endothelial cells than TNF- alpha in vitro.


This article has been cited by other articles:


Home page
J. Nutr.Home page
D. H. Petursdottir, I. Olafsdottir, and I. Hardardottir
Dietary Fish Oil Increases Tumor Necrosis Factor Secretion but Decreases Interleukin-10 Secretion by Murine Peritoneal Macrophages
J. Nutr., December 1, 2002; 132(12): 3740 - 3743.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Grell, H. Wajant, G. Zimmermann, and P. Scheurich
The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor
PNAS, January 20, 1998; 95(2): 570 - 575.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. von Boehmer
Lymphotoxins: From cytotoxicity to lymphoid organogenesis
PNAS, August 19, 1997; 94(17): 8926 - 8927.
[Full Text] [PDF]


Home page
ScienceHome page
P De Togni, J Goellner, N. Ruddle, P. Streeter, A Fick, S Mariathasan, S. Smith, R Carlson, L. Shornick, J Strauss-Schoenberger, et al.
Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin
Science, April 29, 1994; 264(5159): 703 - 707.
[Abstract] [PDF]


Home page
LupusHome page
L. E. Adams, K. Balakrishnan, S. M. Roberts, R. Belcher, A.-B. Mongey, T.J. Thomas, and E. V. Hess
Genetic, Immunologic and Biotransformation Studies of Patients on Procainamide
Lupus, April 1, 1993; 2(2): 89 - 98.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1987 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1987 by The American Association of Immunologists, Inc. All rights reserved.